Federal Reserve Faces Limited Justification for Interest Rate Cuts as Jobs Report Signals Persistent Inflation Pressures Indian Equities and Rupee Edge Higher on RBI Support but Caution Prevails Amid Foreign Outflows Eli Lillys NextGeneration Obesity Drug Retatrutide Shows Positive Results in Pivotal Trial Tesla Launches Full SelfDriving Supervised in China After Years of Delays Amid Fierce Local EV Competition Loop Capital Initiates American Express Coverage with Buy Rating Names Stock Top Pick London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance SHLS Q1 2026 Earnings Earnings Beat Expectations on Improved Margins APG Q1 2026 Earnings EPS Exceeds Expectations Amid Steady Operational Performance Renasant Q1 2026 Earnings EPS Surpasses Estimates as Shares Edge Lower STSS Q3 2025 Earnings EPS Misses Estimates by a Wide Margin as Revenue Remains Unreported MRX Q1 2026 Earnings EPS Beats Estimates by 634 as Stock Declines PEW Q1 2026 Earnings EPS Surprises Positively Despite Broader Market Pressure HP Inc Shares Slip Amid Market Pressure Key Support Levels in Focus Palantir Technologies PLTR Dips 2 Support and Resistance Levels in Focus Saba Capital Income Opportunities Fund II SABA Holds Steady Near Support Amid Low Volatility IRSA Inversiones IRS Holds Steady at 1504 Key Support and Resistance Levels in Focus Hecla Mining Pulls Back from Resistance as Silver Sector Faces Pressure AMTM Q1 2026 Earnings EPS Beats Estimates Stock Rises 293 FITBI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency FTI Consulting FCN Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Uptick Penumbra Q1 2026 Earnings EPS Misses Estimates Stock Slips but Holds Steady SU Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency Amid Market Challenges CRNX Q1 2026 Earnings NarrowerThanExpected Loss as Crinetics Advances Pipeline Broadcom Deepens AI Chip Packaging Collaboration with Applied Materials XENE Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues Fortress Biotech FBIO Gains 162 as Shares Approach Key Resistance at 297